111 related articles for article (PubMed ID: 35188590)
1. Activating KRAS and GNAS mutations in heterotopic submucosal glands of the stomach.
Cho H; Hashimoto T; Naka T; Yatabe Y; Oda I; Saito Y; Yoshikawa T; Sekine S
J Gastroenterol; 2022 May; 57(5):333-343. PubMed ID: 35188590
[TBL] [Abstract][Full Text] [Related]
2. Activating GNAS and KRAS mutations in gastric foveolar metaplasia, gastric heterotopia, and adenocarcinoma of the duodenum.
Matsubara A; Ogawa R; Suzuki H; Oda I; Taniguchi H; Kanai Y; Kushima R; Sekine S
Br J Cancer; 2015 Apr; 112(8):1398-404. PubMed ID: 25867268
[TBL] [Abstract][Full Text] [Related]
3. Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum.
Matsubara A; Sekine S; Kushima R; Ogawa R; Taniguchi H; Tsuda H; Kanai Y
J Pathol; 2013 Mar; 229(4):579-87. PubMed ID: 23208952
[TBL] [Abstract][Full Text] [Related]
4. Morphology and genetics of pyloric gland adenomas in familial adenomatous polyposis.
Hackeng WM; Montgomery EA; Giardiello FM; Singhi AD; Debeljak M; Eshleman JR; Vieth M; Offerhaus GJ; Wood LD; Brosens LA
Histopathology; 2017 Mar; 70(4):549-557. PubMed ID: 27767239
[TBL] [Abstract][Full Text] [Related]
5. Familial adenomatous polyposis-associated and sporadic pyloric gland adenomas of the upper gastrointestinal tract share common genetic features.
Hashimoto T; Ogawa R; Matsubara A; Taniguchi H; Sugano K; Ushiama M; Yoshida T; Kanai Y; Sekine S
Histopathology; 2015 Nov; 67(5):689-98. PubMed ID: 25832318
[TBL] [Abstract][Full Text] [Related]
6. A mutation spectrum that includes GNAS, KRAS and TP53 may be shared by mucinous neoplasms of the appendix.
Hara K; Saito T; Hayashi T; Yimit A; Takahashi M; Mitani K; Takahashi M; Yao T
Pathol Res Pract; 2015 Sep; 211(9):657-64. PubMed ID: 26160192
[TBL] [Abstract][Full Text] [Related]
7. KRAS/GNAS-testing by highly sensitive deep targeted next generation sequencing improves the endoscopic ultrasound-guided workup of suspected mucinous neoplasms of the pancreas.
Schmitz D; Kazdal D; Allgäuer M; Trunk M; Vornhusen S; Nahm AM; Doll M; Weingärtner S; Endris V; Penzel R; Kirchner M; Brandt R; Neumann O; Sültmann H; Budczies J; Kienle P; Magdeburg R; Hetjens S; Schirmacher P; Bergmann F; Rudi J; Stenzinger A; Volckmar AL
Genes Chromosomes Cancer; 2021 Jul; 60(7):489-497. PubMed ID: 33686791
[TBL] [Abstract][Full Text] [Related]
8. GNAS(R201H) and Kras(G12D) cooperate to promote murine pancreatic tumorigenesis recapitulating human intraductal papillary mucinous neoplasm.
Taki K; Ohmuraya M; Tanji E; Komatsu H; Hashimoto D; Semba K; Araki K; Kawaguchi Y; Baba H; Furukawa T
Oncogene; 2016 May; 35(18):2407-12. PubMed ID: 26257060
[TBL] [Abstract][Full Text] [Related]
9. Clinical Impact of KRAS and GNAS Analysis Added to CEA and Cytology in Pancreatic Cystic Fluid Obtained by EUS-FNA.
Faias S; Duarte M; Albuquerque C; da Silva JP; Fonseca R; Roque R; Dias Pereira A; Chaves P; Cravo M
Dig Dis Sci; 2018 Sep; 63(9):2351-2361. PubMed ID: 29796909
[TBL] [Abstract][Full Text] [Related]
10. GNAS
Ideno N; Yamaguchi H; Ghosh B; Gupta S; Okumura T; Steffen DJ; Fisher CG; Wood LD; Singhi AD; Nakamura M; Gutkind JS; Maitra A
Gastroenterology; 2018 Nov; 155(5):1593-1607.e12. PubMed ID: 30142336
[TBL] [Abstract][Full Text] [Related]
11. Oxyntic gland neoplasm of the stomach: expanding the spectrum and proposal of terminology.
Ushiku T; Kunita A; Kuroda R; Shinozaki-Ushiku A; Yamazawa S; Tsuji Y; Fujishiro M; Fukayama M
Mod Pathol; 2020 Feb; 33(2):206-216. PubMed ID: 31375767
[TBL] [Abstract][Full Text] [Related]
12. GNAS mutation as an alternative mechanism of activation of the Wnt/β-catenin signaling pathway in gastric adenocarcinoma of the fundic gland type.
Nomura R; Saito T; Mitomi H; Hidaka Y; Lee SY; Watanabe S; Yao T
Hum Pathol; 2014 Dec; 45(12):2488-96. PubMed ID: 25288233
[TBL] [Abstract][Full Text] [Related]
13. Molecular and clinicopathological features of appendiceal mucinous neoplasms.
Yanai Y; Saito T; Hayashi T; Akazawa Y; Yatagai N; Tsuyama S; Tomita S; Hirai S; Ogura K; Matsumoto T; Wada R; Yao T
Virchows Arch; 2021 Mar; 478(3):413-426. PubMed ID: 32821969
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and molecular correlations in traditional serrated adenoma.
Sekine S; Yamashita S; Yamada M; Hashimoto T; Ogawa R; Yoshida H; Taniguchi H; Kojima M; Ushijima T; Saito Y
J Gastroenterol; 2020 Apr; 55(4):418-427. PubMed ID: 32052185
[TBL] [Abstract][Full Text] [Related]
15. Sporadic pyloric gland adenoma associated with a large fundic gland polyp: genetic evidence for stepwise progression.
Nonaka S; Hashimoto T; Oda I; Sekine S
Gastric Cancer; 2020 Nov; 23(6):1102-1106. PubMed ID: 32415517
[TBL] [Abstract][Full Text] [Related]
16. Value of adding GNAS testing to pancreatic cyst fluid KRAS and carcinoembryonic antigen analysis for the diagnosis of intraductal papillary mucinous neoplasms.
Kadayifci A; Atar M; Wang JL; Forcione DG; Casey BW; Pitman MB; Brugge WR
Dig Endosc; 2017 Jan; 29(1):111-117. PubMed ID: 27514845
[TBL] [Abstract][Full Text] [Related]
17. Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia.
Singhi AD; McGrath K; Brand RE; Khalid A; Zeh HJ; Chennat JS; Fasanella KE; Papachristou GI; Slivka A; Bartlett DL; Dasyam AK; Hogg M; Lee KK; Marsh JW; Monaco SE; Ohori NP; Pingpank JF; Tsung A; Zureikat AH; Wald AI; Nikiforova MN
Gut; 2018 Dec; 67(12):2131-2141. PubMed ID: 28970292
[TBL] [Abstract][Full Text] [Related]
18. Mucinous Adenocarcinoma With Intrapulmonary Metastasis Harboring KRAS and GNAS Mutations Arising in Congenital Pulmonary Airway Malformation.
de Cordova XF; Wang H; Mehrad M; Eisenberg R; Johnson J; Wei Q; Borinstein S; Danko ME; Liang J
Am J Clin Pathol; 2021 Jul; 156(2):313-319. PubMed ID: 33609098
[TBL] [Abstract][Full Text] [Related]
19. Frequent activating GNAS mutations in villous adenoma of the colorectum.
Yamada M; Sekine S; Ogawa R; Taniguchi H; Kushima R; Tsuda H; Kanai Y
J Pathol; 2012 Sep; 228(1):113-8. PubMed ID: 22374786
[TBL] [Abstract][Full Text] [Related]
20. Absence of GNAS and BRAF mutations but presence of KRAS mutation in urachal adenocarcinoma.
Hang JF; Pan CC
Pathology; 2017 Apr; 49(3):316-317. PubMed ID: 28285720
[No Abstract] [Full Text] [Related]
[Next] [New Search]